Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies

被引：0
|
作者：
Petit, P-F. [1 ]
Zhu, J. [1 ]
van den Eynde, B. J. [1 ]
机构：
[1] Ludwig Inst Canc Res, De Duve Inst, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25P
引用
收藏
页码：S1425 / S1425
页数：1
相关论文
共 50 条
  • [41] Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
    Sivan, Ayelet
    Corrales, Leticia
    Hubert, Nathaniel
    Williams, Jason B.
    Aquino-Michaels, Keston
    Earley, Zachary M.
    Benyamin, Franco W.
    Lei, Yuk Man
    Jabri, Bana
    Alegre, Maria-Luisa
    Chang, Eugene B.
    Gajewski, Thomas F.
    SCIENCE, 2015, 350 (6264) : 1084 - 1089
  • [42] Metformin facilitates anti-PD-L1 efficacy through the regulation of intestinal microbiota
    Xiaopeng Zhao
    Chuang Liu
    Licheng Peng
    Hongyan Wang
    Genes & Immunity, 2024, 25 : 7 - 13
  • [43] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Maohua Li
    Rongqing Zhao
    Jianxin Chen
    Wenzhi Tian
    Chenxi Xia
    Xudong Liu
    Yingzi Li
    Song Li
    Hunter Sun
    Tong Shen
    Wenlin Ren
    Le Sun
    Scientific Reports, 11
  • [44] T Cell-Mediated Targeted Delivery of Anti-PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site
    Petit, Pierre -Florent
    Bombart, Raphaele
    Desimpel, Pierre -Hubert
    Naulaerts, Stefan
    Thouvenel, Laurie
    Collet, Jean-Francois
    Eynde, Benoit J.
    Zhu, Jingjing
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (06) : 713 - 727
  • [45] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Li, Maohua
    Zhao, Rongqing
    Chen, Jianxin
    Tian, Wenzhi
    Xia, Chenxi
    Liu, Xudong
    Li, Yingzi
    Li, Song
    Sun, Hunter
    Shen, Tong
    Ren, Wenlin
    Sun, Le
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
    Gao, Tian
    Mao, Zheng
    Li, Wenjing
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (03) : 746 - 756
  • [47] Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
    Zhang, Fei
    Qi, Xiaoqiang
    Wang, Xiaoxiao
    Wei, Diyang
    Wu, Jiawei
    Feng, Lingling
    Cai, Haiyan
    Wang, Yugang
    Zeng, Naiyan
    Xu, Ting
    Zhou, Aiwu
    Zheng, Ying
    ONCOTARGET, 2017, 8 (52) : 90215 - 90224
  • [48] A rare case of pneumocystosis under anti-PD-L1 therapy
    Santos, Maria Joao
    Cavaco, Maria Joao
    Santos, Fernanda Paula
    Froes, Filipe
    PULMONOLOGY, 2024, 30 (06): : 671 - 672
  • [49] Anti-PD-L1 antibody active in metastatic bladder cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2015, 16 (01): : E11 - E11
  • [50] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
12345